← Open Payments lookup

JAMES HOPPER: Open Payments

NPI 1144306283 · AMSTERDAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$319 in 16 payments from 9 companies in 2025. Trend: 2023 $275 · 2024 $518 · 2025 $319

Food & beverage: $319
CompanyPaymentsAmount
Novo Nordisk Inc4$80
Amgen Inc.3$47
GlaxoSmithKline, LLC.2$46
ABBVIE INC.2$42
AstraZeneca Pharmaceuticals LP1$26
Dexcom, Inc.1$23
Exeltis, USA Inc.1$21
PFIZER INC.1$20
Renalytix AI, Inc.1$14

Products named: Ozempic, OTEZLA, QULIPTA, AIRSUPRA, BEXSERO, Dexcom G6 Transmitter, SHINGRIX, SLYND.

Industry payments across NY — which companies pay providers there.